June 10, 2015
A Tribute to Ned Olivier by Jonathan Fleming and Matt Gibbs -- more

May 30, 2015
Obituary - Edmund Olivier, Senior General Partner, Oxford Bioscience Partners -- more

February 17, 2015
VaxInnate Receives Extension of Contract from BARDA for Development of Seasonal and Pandemic Influenza Vaccines -- more

December 21, 2014
Radius Announces Positive Phase 3 Top-Line Results for Its Investigational Drug Abaloparatide-SC in Postmenopausal Women With Severe Osteoporosis -- more

October 28, 2014
Xencor Renegotiates XmAb5871 Agreement with Amgen; Regains All Rights and Plans Clinical Development in Rare Autoimmune Disease -- more

September 2, 2014
Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel -- more

July 16, 2014
Dicerna CEO: Our Technology is Superior, Eyes FDA Approval -- more

June 13, 2014
Enanta Pharmaceuticals Announces U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Regimen for Genotype 1 Chronic Hepatitis C -- more

June 5, 2014
Radius Health, Inc. Announces Pricing of Initial Public Offering -- more

May 28, 2014
Xencor Initiates Phase 1 Study of XmAb7195 for Asthma -- more

May 8, 2014
Enanta Pharmaceuticals Announces Submission of EU Marketing Authorization Applications to the European Medicines Agency for All-Oral, Interferon-Free Hepatitis C Regimen Containing ABT-450 -- more

April 8, 2014
Mitralign Completes Enrollment in EU Study for its Novel Catheter-based Valve Repair Device -- more

Glori Energy IPO

October 28, 2014
Glori Energy Inc. Extends Technology Partnership With Statoil -- more

October 14, 2014
Oil Industry Legend James C. Musselman Joins Glori Energy's Board of Directors -- more

September 9, 2014
Glori Energy Inc. Granted Key US Patent for its AERO(TM) Technology -- more

September 2, 2014
Glori Energy Inc. Acquires $2M East Texas Oil Property -- more

July 16, 2014
Glori Energy FBR Capital Markets Report -- more

June 26, 2014
Glori Energy Set to Join Russell 2000 and 3000 Indexes -- more

June 9, 2014
( GLRI ) SeeThruEquity Initiates Research Coverage on Glori Energy with Target Price of $13.37 -- more

June 3, 2014
Glori Energy Selected as Finalist for the World Petroleum Council Excellence Awards -- more

June 3, 2014
Cambrios Announces Strategic Investment by Samsung Ventures -- more

May 23, 2014
Glori Energy Inc. to Ring The NASDAQ Stock Market Closing Bell -- more